1-159205638-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002036.4(ACKR1):c.199C>T(p.Leu67Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00381 in 1,614,208 control chromosomes in the GnomAD database, including 218 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Affects (no stars).
Frequency
Genomes: 𝑓 0.0060 ( 24 hom., cov: 33)
Exomes 𝑓: 0.0036 ( 194 hom. )
Consequence
ACKR1
NM_002036.4 missense
NM_002036.4 missense
Scores
4
14
Clinical Significance
Conservation
PhyloP100: -0.236
Genes affected
ACKR1 (HGNC:4035): (atypical chemokine receptor 1 (Duffy blood group)) The protein encoded by this gene is a glycosylated membrane protein and a non-specific receptor for several chemokines. The encoded protein is the receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi. Polymorphisms in this gene are the basis of the Duffy blood group system. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0016512573).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0838 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACKR1 | NM_002036.4 | c.199C>T | p.Leu67Phe | missense_variant | 2/2 | ENST00000368122.4 | NP_002027.2 | |
ACKR1 | NM_001122951.3 | c.205C>T | p.Leu69Phe | missense_variant | 2/2 | NP_001116423.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACKR1 | ENST00000368122.4 | c.199C>T | p.Leu67Phe | missense_variant | 2/2 | 1 | NM_002036.4 | ENSP00000357104.1 | ||
ACKR1 | ENST00000368121.6 | c.205C>T | p.Leu69Phe | missense_variant | 2/2 | 6 | ENSP00000357103.2 | |||
ACKR1 | ENST00000435307.2 | n.380C>T | non_coding_transcript_exon_variant | 1/1 | 3 | |||||
CADM3-AS1 | ENST00000609696.1 | n.164+2172G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00601 AC: 915AN: 152232Hom.: 24 Cov.: 33
GnomAD3 genomes
AF:
AC:
915
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0120 AC: 3017AN: 251108Hom.: 124 AF XY: 0.0109 AC XY: 1475AN XY: 135702
GnomAD3 exomes
AF:
AC:
3017
AN:
251108
Hom.:
AF XY:
AC XY:
1475
AN XY:
135702
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00358 AC: 5238AN: 1461858Hom.: 194 Cov.: 36 AF XY: 0.00341 AC XY: 2483AN XY: 727232
GnomAD4 exome
AF:
AC:
5238
AN:
1461858
Hom.:
Cov.:
36
AF XY:
AC XY:
2483
AN XY:
727232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00600 AC: 914AN: 152350Hom.: 24 Cov.: 33 AF XY: 0.00718 AC XY: 535AN XY: 74492
GnomAD4 genome
AF:
AC:
914
AN:
152350
Hom.:
Cov.:
33
AF XY:
AC XY:
535
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
1279
Asia WGS
AF:
AC:
160
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Affects
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Duffy Blood group system Other:1
Affects, no assertion criteria provided | research | Australian Red Cross Blood Service | Jul 01, 2021 | reduced expression of Fy(a) antigen observed. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;.;.;T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
D;D;.;.
Vest4
MPC
0.032
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at